Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Endoplasmin - Pipeline Review, H1 2020
US$ 3,500.00
Endoplasmin - Pipeline Review, H1 2020 SUMMARY Endoplasmin (94 kDa Glucose Regulated Protein or Heat Shock Protein 90 kDa Beta Member 1 or Tumor Rejection Antigen 1 or gp96 Homolog or HSP90B1) - Hea...
February 2020
52 pages
Exportin 1 - Pipeline Review, H1 2020
US$ 3,500.00
Exportin 1 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Exportin 1 - Pipeline Review, H1 2020'; Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1)...
February 2020
107 pages
Frataxin Mitochondrial - Pipeline Review, H1 2020
US$ 3,500.00
Frataxin Mitochondrial - Pipeline Review, H1 2020 SUMMARY Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) pipeline Target constitutes close to 14 molecules. Out of which app...
February 2020
55 pages
Galectin 3 - Pipeline Review, H1 2020
US$ 3,500.00
Galectin 3 - Pipeline Review, H1 2020 SUMMARY Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Lam...
February 2020
81 pages
Iduronate 2 Sulfatase - Pipeline Review, H1 2020
US$ 3,500.00
Iduronate 2 Sulfatase - Pipeline Review, H1 2020 SUMMARY Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Iduronate 2-sulfatase (IDS) is a sulfatase...
February 2020
64 pages
Leukotriene A 4 Hydrolase - Pipeline Review, H1 2020
US$ 3,500.00
Leukotriene A 4 Hydrolase - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Leukotriene A 4 Hydrolase - Pipeline Review, H1 2020'; Leukotriene A 4 Hydrolase (LTA 4 Hydro...
February 2020
50 pages
Midkine - Pipeline Review, H1 2020
US$ 3,500.00
Midkine - Pipeline Review, H1 2020 SUMMARY Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) - Midkine (MDK) or neurite grow...
February 2020
44 pages
Nasal Polyps (Nasal Polyposis) - Pipeline Review, H1 2020
US$ 2,000.00
Nasal Polyps (Nasal Polyposis) - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps - Pipeline Review, H1 2020, provide...
February 2020
107 pages
Prostate Specific Antigen - Pipeline Review, H1 2020
US$ 3,500.00
Prostate Specific Antigen - Pipeline Review, H1 2020 SUMMARY Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Prostate-specif...
February 2020
78 pages
Protein Phosphatase 2A - Pipeline Review, H1 2020
US$ 3,500.00
Protein Phosphatase 2A - Pipeline Review, H1 2020 SUMMARY Protein Phosphatase 2A (PP2A or EC 3.1.3.16) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules are de...
February 2020
51 pages
Tryptophan 2,3 Dioxygenase - Pipeline Review, H1 2020
US$ 3,500.00
Tryptophan 2,3 Dioxygenase - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Tryptophan 2,3 Dioxygenase - Pipeline Review, H1 2020'; Tryptophan 2,3 Dioxygenase (Tryptami...
February 2020
40 pages
Tyrosine Protein Kinase ITK/TSK - Pipeline Review, H1 2020
US$ 3,500.00
Tyrosine Protein Kinase ITK/TSK - Pipeline Review, H1 2020 SUMMARY Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein...
February 2020
66 pages
Free Fatty Acid Receptor 4 - Pipeline Review, H1 2020
US$ 3,500.00
Free Fatty Acid Receptor 4 - Pipeline Review, H1 2020 SUMMARY Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor GT01 or Omega...
February 2020
34 pages
TGF Beta Receptor Type 1 - Pipeline Review, H1 2020
US$ 3,500.00
TGF Beta Receptor Type 1 - Pipeline Review, H1 2020 SUMMARY TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Pro...
February 2020
72 pages
Tyrosine Protein Kinase Mer - Pipeline Review, H1 2020
US$ 3,500.00
Tyrosine Protein Kinase Mer - Pipeline Review, H1 2020 SUMMARY Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Proto-oncogene tyrosine-...
February 2020
69 pages
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline guide also reviews of key players involved in therapeutic development for Uterine Leiomyoma (Uterine Fibroids) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
January 2020
113 pages
Erectile Dysfunction - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Erectile Dysfunction (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Erectile Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
150 pages
Male Hypogonadism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Male Hypogonadism (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Hypogonadism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
107 pages
Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Ventilator Associated Pneumonia (VAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
176 pages
Amyloidosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Amyloidosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Amyloidosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
226 pages
Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Onychomycosis (Tinea Unguium) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
83 pages
Rheumatoid Arthritis - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Rheumatoid Arthritis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
1156 pages
Smallpox - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Smallpox (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Smallpox and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
81 pages
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Acute Respiratory Distress Syndrome (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Acute Respiratory Distress Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
January 2020
129 pages
Cholera - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cholera (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cholera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
63 pages
Typhoid Fever - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Typhoid Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
52 pages
Diabetic Macular Edema - Pipeline Review, H1 2020
US$ 2,000.00
... . The Diabetic Macular Edema (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Macular Edema and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
298 pages
Sarcopenia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Sarcopenia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sarcopenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
91 pages
Anthrax - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Anthrax (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
110 pages
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Hospital Acquired Pneumonia (HAP) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hospital Acquired Pneumonia (HAP) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
January 2020
199 pages
